Fig. 2From: Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patientsKaplan–Meier curves showing the relation between the OS and the proportion of CD8 lymphocytes positive to PD-1 (a) together with CD73 (b) before treatment with nivolumab. P values were calculated by log-rank testBack to article page